Skip to main content
. Author manuscript; available in PMC: 2007 Sep 17.
Published in final edited form as: J Am Soc Nephrol. 2007 Apr 4;18(5):1576–1583. doi: 10.1681/ASN.2006111263

Figure 1.

Figure 1

The effect of changing the dosing frequency of agalsidase alfa from every other week (EOW) to weekly in patients whose estimated GFR (eGFR) declines at >5 ml/min per 1.73 m2/yr during long-term EOW therapy. Each symbol represent an individual patient, and the squares represent the mean ± SEM during EOW and weekly dosing.